OIG - Office of Inspector General
09/30/2024 | Press release | Distributed by Public on 10/01/2024 07:26
Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved Drug
Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved Drug
The founder and chief executive officer of a California-based company that marketed stem cell-based products allegedly linked to 19 hospitalizations was sentenced today to 36 months in prison following his conviction under the Federal Food, Drug and Cosmetic Act.
Action Details
- Date:September 30, 2024
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
Share
OIG - Office of Inspector General published this content on September 30, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2024 at 13:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]